Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

SAM2® Biotin Capture Membrane Technical Bulletin

Instructions for Use of Product(s)

Literature # TB547

The SAM2® Biotin Capture Membrane binds biotinylated molecules based on their affinity for streptavidin. The proprietary process by which the SAM2® Membrane is produced results in a high density of streptavidin on the filter, providing rapid, quantitative substrate binding in the nmol/cm2 range. In addition, the membrane is optimized for low nonspecific binding. The membrane is available either as a large, prenumbered, partially cut sheet (approximately 10.5 × 15.0cm; Cat.# V2861) or as a smaller, uncut sheet (approximately 7.6 × 10.9cm; Cat.# V7861). The partially cut membrane (Cat.# V2861) allows easy separation into 96 individual squares and is designed for small-scale experiments where high binding capacity is required. The uncut sheet (Cat.# V7861) can be analyzed as a whole membrane or may be cut into the size desired. The uncut membrane allows sample application using a multichannel pipettor. Both membranes may be analyzed using phosphorimaging, autoradiography or scintillation counting to quantitate results. The membranes also have been used successfully with chemiluminescence detection techniques. The use of fluorescence to detect captured molecules is not recommended at this time. The SAM2® Membrane, used as recommended in this technical bulletin, provides a number of advantages over other commercially available streptavidin products.

Printed in USA. Revised 1/13.